| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.90B | $6.15B | $5.48B |
| YoY Revenue Growth % | +12.2% | +12.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.16B | $1.01B | $921.8M |
| Operating Margin % | 16.9% | 16.4% | 16.8% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $2.98B | $2.44B | $1.12B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.34B | $1.20B | $1.11B |
| Capital Expenditures (CapEx) | $2.27B | $1.79B | $246.6M |
| Free Cash Flow (FCF) | -$931.6M | -$594.9M | $867.0M |
| FCF Margin % | -13.5% | -9.7% | 15.8% |
| Return on Invested Capital (ROIC %) | 6.1% | 6.5% | 6.2% |
| Cash & Short-Term Equivalents | $158.5M | $155.7M | — |
| Total Debt (Short + Long Term) | $16.22B | $13.00B | $4.54B |
| Total Stockholders' Equity | -$981.0M | -$503.1M | $9.30B |